Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2022, Vol. 36 ›› Issue (2): 96-99.doi: 10.6040/j.issn.1673-3770.0.2021.400
Previous Articles Next Articles
PAN Yanli1,2, LI Yuanbin2
CLC Number:
[1] 白冰,方晏红. 中重度眼化学伤急性期处理及羊膜移植的疗效观察[J].国际眼科杂志,2014,14( 4): 714-716. doi: 10.3980 /j. issn.1672-5123.2014.04.40. BAI Bing, FANG Yanhong. Clinical observation of acute treatment of moderate and severe ocular chemical injury and amniotic membrane transplantation[J]. International Journal of Ophthalmology, 2014, 14(4): 714-716. doi: 10.3980 / J.issn.1672-5123.2014.04.40. [2] 刘家琦, 李凤鸣. 实用眼科学[M]. 3版. 北京: 人民卫生出版社,2020. [3] 彭丽, 谢青, 陈敏华. 抗VEGF治疗在眼科的临床意义及研究进展[J]. 国际眼科杂志, 2020, 20(2):282-285. doi:10.3980/j.issn.1672-5123.2020.2.20. PENG Li, XIE Qing, CHEN Min-Hua. Clinical significance and recent research advances of anti-VEGF treatment in ophthalmology[J]. International Eye Science, 2020, 20(2): 282-285. doi:10.3980/j.issn.1672-5123.2020.2.20. [4] Gal-Or O, Livny E, Sella R, et al. Efficacy of subconjunctival aflibercept versus bevacizumab for prevention of corneal neovascularization in a rat model[J]. Cornea, 2016, 35(7): 991-996. doi:10.1097/ICO.0000000000000849. [5] Chang JH, Garg NK, Lunde E, et al. Corneal neovascularization: an anti-VEGF therapy review[J]. Surv Ophthalmol, 2012, 57(5): 415-429. doi:10.1016/j.survophthal.2012.01.007. [6] Keating AM, Jacobs DS. Anti-VEGF treatment of corneal neovascularization[J]. Ocul Surf, 2011, 9(4): 227-237. doi:10.1016/s1542-0124(11)70035-0. [7] Ucgul Rukiye Kilic, Celebi Serdal, Yilmaz Niyazi Samet, et al. Intrastromal versus subconjunctival anti-VEGF agents for treatment of corneal neovascularization: a rabbit study[J]. Eye, 2021, 35(11): 3123-3130. doi:10.1038/s41433-020-01347-3. [8] Papathanassiou M, Theodoropoulou S, Analitis A, et al. Vascular endothelial growth factor inhibitors for treatment of corneal neovascularization: a meta-analysis[J].Cornea, 2013, 32(4): 435-444. doi:10.1097/ICO.0b013e3182542613. [9] Nava-Castañeda A, Olvera-Morales O, Ramos-Castellon C, et al. Randomized, controlled trial of conjunctival autografting combined with subconjunctival bevacizumab for primary pterygium treatment: 1-year follow-up[J]. Clin Experiment Ophthalmol, 2014, 42(3): 235-241. doi:10.1111/ceo.12140. [10] Ozgurhan EB, Agca A, Kara N, et al. Topical application of bevacizumab as an adjunct to recurrent pterygium surgery[J]. Cornea, 2013, 32(6): 835-838. doi:10.1097/ICO.0b013e3182772d4e. [11] Sun Y, Zhang BW, Jia XH, et al. Efficacy and safety of bevacizumab in the treatment of pterygium: an updated meta-analysis of randomized controlled trials[J]. J Ophthalmol, 2018, 2018: 4598173. doi:10.1155/2018/4598173. [12] Zeng W, Liu ZM, Dai HJ, et al. Anti-fibrotic, anti-VEGF or radiotherapy treatments as adjuvants for pterygium excision: a systematic review and network meta-analysis[J]. BMC Ophthalmol, 2017, 17(1): 211. doi:10.1186/s12886-017-0601-5. [13] Mohamed TA, Soliman W, Fathalla AM, et al. Effect of single subconjunctival injection of bevacizumab on primary pterygium: clinical, histopathological and immunohistochemical study[J]. Int J Ophthalmol, 2018, 11(5): 797-801. doi:10.18240/ijo.2018.05.13. [14] Sacchetti M, Rama P, Bruscolini A, et al. Limbal stem cell transplantation: clinical results, limits, and perspectives[J]. Stem Cells Int, 2018, 2018: 8086269. doi:10.1155/2018/8086269. [15] 李楠钰, 张文佳, 胡竹林. 羊膜在眼表疾病治疗的研究进展[J]. 国际眼科纵览, 2019, 43(2): 94-99. doi:10.3760/cma.j.issn.1673-5803.2019.02.005. LI Nanyu, ZHANG Wenjia, HU Zhulin. Advances in the treatment of ocular surface diseases by amniotic membrane[J]. International Review of Ophthalmology, 2019, 43(2): 94-99. doi:10.3760/cma.j.issn.1673-5803.2019.02.005. [16] 李保江, 李霞, 高晓唯, 等. 自体角膜缘干细胞分期移植治疗中重度眼部碱烧伤[J]. 国际眼科杂志, 2007, 7(5): 1444-1446. doi:10.3969/j.issn.1672-5123.2007.05.075. LI Baojiang, LI Xia, GAO Xiaowei, et al. Corneal limbus stem cell autograft for moderate-severe ocular alkaline burn by stages[J]. International Eye Science, 2007, 7(5): 1444-1446. doi:10.3969/j.issn.1672-5123.2007.05.075. |
[1] | Keyang HAN,Beibei YU,Bojun ZHAO. Morphological structure analysis of the macular area after anti-VEGF treatment for short-term retinal vein occlusion [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(5): 129-131. |
[2] | . The pathogenesis of RVO and anti-VEGF treatment for its macular edema. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(1): 123-126. |
[3] | WANG Yuxia, XIAO Ying, SUN Hongyi, GAO Xue, LIU Jing, CHEN Guoling, YANG Lixia. Four surgical treatments of pterygium on 168 eyes [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2010, 24(3): 64-66. |
[4] | WANG Zhen,SHEN Jiaquan,ZHANG Shixi. Trabeculectomy with mitomycin-C and amniotic membrane transplantation and adjustable suture for refractory glaucoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2009, 23(6): 67-70. |
|